Placebo use in vaccine trials: Recommendations of a WHO expert panel

Vaccine

Volumn 32, Issue 37, 2014, Pages 4708-4712

  Rid, Annette ^a   Saxena, Abha ^b   Baqui, Abdhullah H ^c   Bhan, Anant ^d   Bines, Julie ^e   Bouesseau, Marie Charlotte ^b   Caplan, Arthur ^f   Colgrove, James ^g   Dhai, Ames ^h   Gomez Diaz, Rita ⁱ   Green, Shane K ^d   Kang, Gagandeep ^j   Lagos, Rosanna ^k   Loh, Patricia ^l   London, Alex John ^m   Mulholland, Kim ⁿ   Neels, Pieter ^o   Pitisuttithum, Punee ^p   Sarr, Samba Cor ^q   Selgelid, Michael ^r   Sheehan, Mark ^s   Smith, Peter G ⁿ   more..

^a KING'S COLLEGE LONDON   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Columbia University ^*  (United States)

^h UNIVERSITY OF THE WITWATERSRAND   (South Africa)

ⁱ INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^j CHRISTIAN MEDICAL COLLEGE   (India)

^k HOSPITAL ROBERTO DEL RÍO   (Chile)

^l UNIVERSITY OF MELBOURNE   (Australia)

^m CARNEGIE MELLON UNIVERSITY   (United States)

ⁿ LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^o Vaccine Advice BVBA ^*  (Belgium)

^p MAHIDOL UNIVERSITY   (Thailand)

^q Ministry of Health and Social Action 1   (Senegal)

^r MONASH UNIVERSITY   (Australia)

^s UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

Ethics; International research; Placebo controls; Risk; Trial design; Vaccine trials

Indexed keywords

PLACEBO; VACCINE;

CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); DEMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; EPIDEMIOLOGICAL DATA; HUMAN; INFECTION; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH; RESEARCH ETHICS; STUDY DESIGN; WORLD HEALTH ORGANIZATION; ETHICS; METHODOLOGY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

GUIDELINES AS TOPIC; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; VACCINES; WORLD HEALTH ORGANIZATION;

EID: 84905221885     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.04.022     Document Type: Note

References (22)

1. Murray C.J., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2197-2223.
2. World Health Organization (WHO) Ethical considerations arising from vaccine trials conducted in paediatric populations with high disease burden in developing countries 2002, WHO, Geneva.
3. Joint United Nations Porgramme on HIV/AIDS (UNAIDS), World Health Organization (WHO) Ethical considerations in biomedical HIV prevention trials. UNAIDS/WHO guidance document 2012, UNAIDS, Geneva.
4. World Medical Association (WMA) WMA Declaration of Helsinki-ethical principles for medical research involving human subjects 2013, WMA, Ferney-Voltaire.
5. Council for International Organizations of Medical Sciences (CIOMS) International ethical guidelines for biomedical research involving human subjects 2002, CIOMS, Geneva.
6. Council of Europe (CoE) Additional protocol to the convention on human rights and biomedicine, concerning biomedical research 2005, CoE, Strasbourg.
7. Indian Council of Medical Research (ICMR) Ethical guidelines for biomedical research on human participants 2006, ICMR, New Delhi.
8. South African Medical Research Council (SAMRC) Guidelines on ethics for medical research: general principles, including research on children, vulnerable groups, international collaboration and epidemiology 2002, SAMRC, Tygerberg.
9. Uganda National Council for Science and Technology (UNCST) National guidelines for research involving humans as research participants 2007, UNCST, Kampala.
10. Comissão Nacional de Ética em Pesquisa (CONEP), Conselho Nacional de Saúde de Brazil RESOLUÇÃO CNS no. 404 2008, CONEP, Brasília.
11. Nuffield Council on Bioethics The ethics of research related to healthcare in developing countries 2002, Nuffield Council, London.
12. U.S.Food and Drug Administration Human subject protection: foreign clinical studies not conducted under an investigational new drug application: final rule. Fed Regis 2008, 73(82):22800-22816.
13. World Health Organization (WHO) Expert consultation on the use of placebos in vaccine trials 2013, WHO, Geneva.
14. Vesikari T. Rotavirus vaccination: a concise review. Clin Microbiol Infect 2012, 18(Suppl 5):57-63.
15. Bhandari N., Rongsen-Chandola T., Bavdekar A., John J., Antony K., Taneja S., et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet 2014, (early online publication). 10.1016/S0140-6736(13)62630-6.
16. Cutts F.T., Zaman S.M., Enwere G., Jaffar S., Levine O.S., Okok J.B., et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005, 365(9465):1139-1146.
17. Eriksson A., Burcharth J., Rosenberg J. Animal derived products may conflict with religious patients' beliefs. BMC Med Ethics 2013, 14:48.
18. Gupte M.D., Vallishayee R.S., Anantharaman D.S., Nagarju B., Sreevatsa Balasubramanyam S., et al. Comparative leprosy vaccine trial in south India. Indian J Lepr 1998, 70(4):369-388.
19. Gessner B.D., Sutanto A., Linehan M., Djelantik I.G., Fletcher T., Gerudug I.K., et al. Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Lancet 2005, 365(9453):43-52.
20. Desai R., Oliveira L.H., Parashar U.D., Lopman B., Tate J.E., Patel M.M. Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America - a review. Mem Inst Oswaldo Cruz 2011, 106(8):907-911.
21. RTS S. Clinical trials partnership. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med 2012, 367(24):2284-2295.
22. Olotu A., Lusingu J., Leach A., Lievens M., Vekemans J., Msham S., et al. Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial. Lancet Infect Dis 2011, 11(2):102-109.